Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy

L. Yuan, M. Siegel, K. Choi, C. Khosla, C. R. Miller, E. N. Jackson, D. Piwnica-Worms, K. M. Rich

Research output: Contribution to journalArticlepeer-review

129 Citations (Scopus)

Fingerprint Dive into the research topics of 'Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences